CIBC Private Wealth Group LLC Has $23.95 Million Position in Revvity Inc. $RVTY

CIBC Private Wealth Group LLC lessened its stake in Revvity Inc. (NYSE:RVTY) by 2.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 273,207 shares of the company’s stock after selling 6,473 shares during the period. CIBC Private Wealth Group LLC’s holdings in Revvity were worth $23,947,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. AQR Capital Management LLC increased its position in shares of Revvity by 5.2% during the first quarter. AQR Capital Management LLC now owns 8,449 shares of the company’s stock valued at $883,000 after purchasing an additional 420 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Revvity by 6.7% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company’s stock worth $1,246,000 after purchasing an additional 744 shares during the period. Millennium Management LLC lifted its position in Revvity by 102.0% in the first quarter. Millennium Management LLC now owns 69,401 shares of the company’s stock worth $7,343,000 after purchasing an additional 35,048 shares during the period. Goldman Sachs Group Inc. boosted its stake in Revvity by 45.5% during the first quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company’s stock worth $64,232,000 after buying an additional 189,871 shares in the last quarter. Finally, Focus Partners Wealth boosted its stake in Revvity by 13.0% during the first quarter. Focus Partners Wealth now owns 7,028 shares of the company’s stock worth $744,000 after buying an additional 811 shares in the last quarter. 86.65% of the stock is owned by institutional investors and hedge funds.

Revvity Price Performance

NYSE:RVTY opened at $85.79 on Friday. The company has a quick ratio of 1.40, a current ratio of 1.68 and a debt-to-equity ratio of 0.36. The firm has a market cap of $9.59 billion, a PE ratio of 41.24, a price-to-earnings-growth ratio of 1.80 and a beta of 1.10. Revvity Inc. has a 12 month low of $81.36 and a 12 month high of $118.30. The company’s 50-day moving average price is $100.93 and its two-hundred day moving average price is $96.40.

Revvity (NYSE:RVTY) last posted its earnings results on Monday, February 2nd. The company reported $1.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.15. Revvity had a return on equity of 7.92% and a net margin of 8.45%.The firm had revenue of $772.06 million during the quarter, compared to analysts’ expectations of $759.81 million. During the same period in the previous year, the firm earned $1.42 earnings per share. The company’s revenue was up 5.9% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. On average, equities analysts anticipate that Revvity Inc. will post 4.94 EPS for the current fiscal year.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Friday, April 17th will be given a $0.07 dividend. The ex-dividend date is Friday, April 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. Revvity’s payout ratio is currently 13.46%.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on RVTY. Evercore raised their price objective on shares of Revvity from $112.00 to $118.00 and gave the stock an “outperform” rating in a report on Tuesday, February 3rd. Wall Street Zen raised shares of Revvity from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. TD Cowen reissued a “hold” rating on shares of Revvity in a research report on Tuesday, February 3rd. Jefferies Financial Group raised their price target on shares of Revvity from $100.00 to $105.00 and gave the stock a “hold” rating in a research note on Monday, February 2nd. Finally, Bank of America lowered Revvity from a “buy” rating to a “neutral” rating and set a $110.00 price objective on the stock. in a research note on Monday, December 15th. Five analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $113.67.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.